(888) 391-1315

53ab241127ee4a612ed1b0c0_Icon-arrow-top.png

IN THE NEWS

FDA & Studies Warn of Hernia Mesh Implant Side Effects As Lawsuits Grow

Tuesday, January 10, 2017

Abdominal hernias are a common injury that will affect more than 25% of all men and even some women during their lifetime. And, for the most part, they are resolved with a simple surgery. Each year, more than 350,000 people in the United States undergo hernia repair procedures.

Hernia repair may be performed with only sutures. However, for over 50 years, doctors have done most hernia repairs with a lightweight plastic mesh that bonds to the abdominal wall with scar tissue to add strength.

Read More

Report: Xarelto & Eliquis Top List for Doctor Payouts Last Year

Tuesday, January 10, 2017

With a blood thinner market estimated at over $6 billion per year, three manufacturers have been fighting it out to get their drugs – Pradaxa, Xarelto and Eliquis – prescribed to as many patients as possible.

Never mind that these drugs have been linked to serious internal bleeding and death; or that, to this day, thousands of lawsuits have been filed and billions of dollars will be paid out to victims. The makers are determined to increase their market share by any means necessary.

Read More

Pradaxa Maker Tries to Block New Lawsuit from Deceased Victim's Family

Wednesday, November 16, 2016

Since the blood thinner Pradaxa burst onto the scene in 2010, experts have debated whether the drug is safer or riskier than stalwart Coumadin, even as thousands of patients have died or been hospitalized due to internal bleeding.

In 2014, faced with more than 4,000 patient lawsuits, Pradaxa maker Boehringer Ingelheim decided to pay $650 million to settle cases rather than face charges in a public court of law. And, by all accounts, the company thought that was the last of the Pradaxa lawsuits.

Read More

Canada's FDA Issues Recall of Stryker Hip Implants

Friday, November 04, 2016

Last week, DrugNews reported on a warning issued by Stryker Orthopedics for its LFit V40 femoral head used on several models of its hip replacement implants. Although the warning was sent only to doctors, experts believe the safety risks could result in a worldwide recall.

Now, Canada’s top health authority has issued a formal recall of these hip implant components, citing a higher-than-normal number of patient injuries.

Read More

New Warning Issued for Stryker Hip Implants

Tuesday, October 25, 2016

Stryker Orthopedics, a market leader in hip and knee replacement implants, has sold millions of devices in recent decades. However, they have also recalled several of those implants due to serious health risks, with at least four recalls issued since 2009.

This summer, Stryker took the first step toward what many believe may be their latest hip recall when they issued a private letter to doctors warning of risks with their LFit V40 femoral head, which is used on several hip replacement models.

Read More

FDA & British Medical Journal Disagree on Safety of Xarelto

Thursday, October 20, 2016

There’s been much debate about the safety of the anticoagulant Xarelto since it first hit the market in 2011. Despite claims the drug is safer than traditional warfarin, studies and thousands of patient lawsuits suggest it can cause serious internal bleeding with greater chances of death.

Last year, reports surfaced that a key device used in the initial clinical trial testing of Xarelto was defective, calling into question whether the results were valid.

Read More

New Reports Question Safety of IVC Blood Clot Filters As Lawsuits Mount

Wednesday, October 19, 2016

Amid recent questions over the safety of Inferior Vena Cava blood clot filters, two new reports warn of their immanent dangers and a federal judicial panel has disclosed a surge in lawsuits filed by injured patients.

Inferior Vena Cava (IVC) filters are tiny, metal vein implants that catch blood clots before they reach the heart or lungs. They are generally used in emergencies or for those who can’t take blood thinners. Each year, they are used in around 250,000 patients.

Read More

DrugNews' Weekly FDA Recall & Warning Report for September 29, 2016

Friday, September 30, 2016

This week, DrugNews highlights eight recalls announced by the U.S. Food and Drug Administration during the month of September. Seven of these involved food products while one dealt with a line of injectable drugs.

Below you will find more information on the recalls, and what consumers need to know for their safety.

Read More

Victims Ask to Consolidate Invokana Kidney Lawsuits as New Data Raises Questions

Monday, September 26, 2016

Amid mounting FDA warnings that the diabetes drug Invokana may cause kidney damage, a new study out last month confused the issue by suggesting the drug may actually slow kidney damage.

The data comes as the growing number of lawsuits against the manufacturer of Invokana, Johnson & Johnson, has led to victims requesting that cases be consolidated to a central federal court for quicker handling.

Read More

Will Xarelto, Eliquis Antidote Come in Time to Save Thousands?

Thursday, September 15, 2016

Last month DrugNews reported that the FDA had delayed approval of an antidote for new age blood thinning drugs Eliquis and Xarelto due to questions with the manufacturing process.

Now, as the number of patients injured or killed by uncontrollable internal bleeding continues to rise, new data suggests the experimental antidote could help save as many as 90% of them from the risk.

Read More

prev 1 2 3 4 5 6 7 8 9 10 11 next